Hypothesizing the Genesis of Infectious Diseases and Epidemics Through an Integrated Systems Biology Approach

NACompletedINTERVENTIONAL
Enrollment

249

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

December 18, 2024

Study Completion Date

June 30, 2025

Conditions
SARS-CoV-2 InfectionInfluenza Viral Infections
Interventions
BIOLOGICAL

blood samples, urine samples and nasopharyngeal swabs

The following samples will be collected: First time point : 6 blood sample tubes (5mL EDTA, 5mL heparinized and 7.5mL heparinized, 5mL citrate, 5mL serum, 5mL Tempus Blood RNA Tube); 1 urine sample (10mL in a sterile collector) and 1 naso-pharyngeal swab (1mL UT medium). Second time point : 5 blood sample tubes (5mL EDTA,5mL heparinized and 7.5mL heparinized, 5mL serum, 5mL Tempus Blood RNA Tube); 1 urine sample (10mL in a sterile collector) and 1 naso-pharyngeal swab (1mL UT medium).

Trial Locations (1)

1200

Cliniques Universitaires Saint-Luc, Brussels

All Listed Sponsors
lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER